Your top market headlines for today

Is the market primed for a bounce? What's going on with Rivian and Lucid? and more

 ‌ ‌ ‌ 

[Preheader]  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Insider Edge Daily Digest Top Headlines for Tuesday, Apr, 23, 2024

The Billionaire Wave Unlock a billion dollars with this breakthrough - Sponsored Scientific references and supportive clinical studies from Harvard University, Columbia University, The Journal of Neuroscience and more... Read more benzinga.com Why Cidara Therapeutics (CDTX) Stock Is Falling Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split. Read more benzinga.com Deep Dive Into Genpact Stock: Analyst Perspectives (4 Ratings) Deep Dive Into Genpact Stock: Analyst Perspectives (4 Ratings) - Genpact (NYSE:G) Read more WealthDNA WARNING: Controversial information leaked by a rogue NASA scientist - Sponsored This was supposed to be a secret that the elites kept to themselves. And the 1%ers people are afraid that if everyone activates their Wealth DNA, they won't be able to keep a stranglehold on the world's wealth. Read more benzinga.com What's Going On With Rivian Stock? Rivian shares are trading lower by 1.5% during Monday's session. The EV sector may be trading lower in sympathy with Tesla after the company reduced vehicle prices. Read more benzinga.com Beyond The Numbers: 13 Analysts Discuss Braze Stock Beyond The Numbers: 13 Analysts Discuss Braze Stock - Braze (NASDAQ:BRZE) Read more VIP Indicators Win up to 93% of your trades with this secret... - Sponsored Imagine having an expert trading assistant who helps you understand when to buy or sell in the trading world... Read more benzinga.com Why NewGenIvf Stock Is Blasting Higher The term sheet proposed that NewGen issue 53,600,000 of its ordinary shares to the shareholder(s) of EWIHL in exchange for 100% equity interest of EWIHL, at a price per share of $5, representing an aggregate amount of $268 million. Simultaneously, it is proposed that NewGen raise $30 million from public or private shareholders, in a form mutually acceptable to both NewGen and EWIHL. Read more benzinga.com Analyst Eyes Papa John's Comparable Sales Amid Price-Value Concerns, Upgrades Stock To Hold Stifel's Chris O'Cull shifts stance on Papa John's International to Hold, citing pragmatic near-term outlook. Despite lowering the price target to $60 amidst market turbulence, O'Cull emphasizes the stock's resilience. With -1% domestic comparable sales in Q1, challenges persist, particularly in a fiercely competitive market. Read more benzinga.com Pepsi Stock Chart Looks Bullish Ahead Of Q1 Ratings, But Analysts Are Cautious Pepsi will report Q1 earnings on April 23 before market hours. The most recent analyst ratings project an average price target of $131. Read more benzinga.com What's Going On With Luxury EV-Maker Lucid's Stock? Last week, Lucid revealed new details about the 2024 Lucid Air Grand Touring, including an EPA-estimated range of 516 miles, the longest range of any EV in the U.S. market currently, and a starting price of $109,900. Read more benzinga.com Why Is Cardinal Health Stock Trading Lower On Monday? Discover the latest updates on Cardinal Health's nonrenewal of OptumRx contracts. Explore its fiscal 2024 guidance and long-term targets amidst market shifts. Learn about its strategies to offset contract impact and drive growth. Read more cnbc.com The stock market is primed for a short-term bounce, but correction still not over Wall Street technical analysts expect equities may see a tactical bounce after recent declines. The S&P 500 is coming off its worst week in more than a year. Read more

This email contains informational content, including charts and examples, solely for educational and illustrative purposes, rather than personalized investment advice. It features commercial content, such as advertisements and offers from partners from which we may earn affiliate compensation, sent exclusively to subscribers of our newsletter. Should you wish to unsubscribe from receiving these offers, please use the link provided at the bottom of this email. Please note that past performance does not guarantee future results, and we highly recommend practicing with a simulated account. The content herein is intended for educational and informational use only. We do not endorse or guarantee the accuracy, reliability, or integrity of any products, practices, or procedures mentioned or advised in this message or its linked sources. Any actions taken based on this email's content or links are at your own risk, and by doing so, you agree to absolve us, along with our officers, directors, shareholders, affiliates, and agents, from liability. InsiderEdge | All rights reserved. Unsubscribe